Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hematologic Neoplasms × lenvatinib × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 33 Cholangiocarcinoma 11 Carcinoma, Renal Cell 7 Stomach Neoplasms 5 Neoplasms 4 Liver Neoplasms 4 Uterine Cervical Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Vulvar Neoplasms 1 Urogenital Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1

Interventions

Cyclophosphamide 21 fludarabine 18 venetoclax 8 Mycophenolic Acid 8 Whole-Body Irradiation 7 fludarabine phosphate 6 Standard of Care 6 Sirolimus 6 Mesna 6 Melphalan 6 Azacitidine 6 Tacrolimus 5 thymoglobulin 4 Thiotepa 4 Specimen Handling 4 Practice Guidelines as Topic 4 Filgrastim 4 Cytarabine 4 Blood Specimen Collection 4 pegylated granulocyte colony-stimulating factor 3 daratumumab 3 cobimetinib 3 Vemurafenib 3 Surveys and Questionnaires 3 Palliative Care 3 Granulocyte Colony-Stimulating Factor 3 Busulfan 3 Bortezomib 3 Behavior Therapy 3 tagraxofusp 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03486873 2026-03-16

MK-3475-587

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡